Dozens of genes tied to OCD and tic disorders discovered
· Medical Xpressedited by Swati Mestri, reviewed by Robert Egan
Swati Mestri
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Senior Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
A Rutgers-led international collaboration has identified 36 genes that substantially raise the risk of obsessive-compulsive disorder (OCD) and chronic tic disorders—providing, two researchers said, the most detailed biological understanding of how these conditions develop and might eventually be treated.
Before this study, published in Nature Neuroscience, scientists had found a few genetic clues, each linked separately to OCD or chronic tic disorders.
Gary Heiman, a professor in the Department of Genetics in the Rutgers School of Arts and Sciences and a senior co-author of the study, said the research "dramatically expands the catalog of shared risk genes, reveals biological connections with autism and schizophrenia and highlights the brain circuits that govern impulse control, movement and habit formation."
OCD is characterized by persistent intrusive thoughts and repetitive behaviors, while chronic tic disorders, including Tourette syndrome, involve sudden, repeated movements or vocalizations that are difficult to control. Together, the conditions affect millions worldwide, often beginning in childhood and frequently co-occurring within the same individuals and families, according to the National Institutes of Health.
"In the past we knew about a couple of strong genes, so there were few opportunities for the pharmaceutical industry to develop drugs," said Jay Tischfield, a pioneer in the study of Tourette syndrome, an emeritus Distinguished Professor in the Department of Genetics at Rutgers and a senior co-author of the study. "Now you've got over 30 targets, and that opens up new possibilities for treatment development."
Shared genes point to common biology
The study analyzed DNA from nearly 4,000 people diagnosed with OCD, chronic tic disorders such as Tourette syndrome or both conditions. Researchers focused on rare mutations that disrupt genes that help build and operate the brain.
Many of the newly identified genes are shared between OCD and chronic tic disorders. The findings help explain why the conditions often occur together in the same people and families. At the biological level, the disorders appear to involve many of the same brain pathways.
"These genes don't act individually," said Tischfield, who, along with Heiman, is also affiliated with Rutgers' Human Genetics Institute of New Jersey. "They act in networks. And now you can target whole networks, which will make it easier to design new therapies."
The researchers also found that several of the newly identified genes were previously linked to autism and schizophrenia, reinforcing increasing evidence that multiple psychiatric conditions may stem from related disruptions in brain development and communication.
Brain cells communicate using chemical signals called neurotransmitters that carry messages from one nerve cell to another. The genes identified in the study appear to influence how those signals move through the brain's circuitry.
By revealing the biological systems behind the disorders, the findings could help scientists design drugs that target the underlying mechanisms rather than simply managing symptoms.
Clues from brain regions and DNA
The researchers said their study also provides new insight into where these processes occur in the brain. Analyses of gene activity suggest many of the risk genes are active in regions involved in movement, decision-making and habit formation, including parts of the cortex and striatum.
The work was driven by a major international collaboration that combined genetic data from more than 30 research teams across the United States, Canada, Europe, South Korea and South America. To look for clues in the DNA, scientists used whole-exome sequencing, a technique that reads the sections of genes that instruct the body how to make proteins. Rutgers researchers helped design the project, curate clinical data and oversee genetic sequencing.
Researchers compared gene sequences from affected individuals with those of their parents and controls. In many cases, they identified new mutations that appeared in the child but not in either parent, helping pinpoint genes that likely play a role in the disorders.
"This study really moves the field forward," said Heiman. "We now have a much clearer picture of what's causing these disorders and many more directions to pursue as we work toward better treatments."
Heiman and Tischfield have collaborated on genetic studies of brain disorders since 2007.
Families made the data possible
The researchers said the study wouldn't have been possible without the long-term commitment of families who volunteered their DNA samples long before modern sequencing technologies existed.
"When we began collecting these samples 20 years ago, we did not yet have the rapid and cost-effective technologies we have today," said Heiman, adding that the samples were stored at the Rutgers Repository. "Families volunteered because they wanted to help scientists understand these conditions. Now, with modern genome sequencing, those samples have become incredibly valuable."
Many of those families were recruited through the New Jersey Center for Tourette Syndrome and Associated Disorders and other research programs throughout the world. Their contributions allowed scientists to build the large genetic data sets needed to detect rare mutations and identify the genes involved.
Other Rutgers researchers involved in the study included Jinchuan Xing, a professor in the Department of Genetics; Max Tischfield, an assistant professor in the Department of Cell Biology and Neuroscience; Joshua Thackray, a clinical research data engineer with the Office of Advanced Research Computing; Cara Nasello, a research associate in the Department of Genetics and the Department of Cell Biology and Neuroscience; and Danea Glover, a program coordinator in the Rutgers Human Genetics Institute of New Jersey.
Publication details
Whole-exome sequencing in individuals with obsessive–compulsive disorder and chronic tic disorders identifies 36 large-effect risk genes, Nature Neuroscience (2026). DOI: 10.1038/s41593-026-02419-5
Journal information: Nature Neuroscience
Key medical concepts
Obsessive-Compulsive DisorderComplete Exome Sequencings
Clinical categories
PsychiatryClinical geneticsNeurology Provided by Rutgers University Who's behind this story?
Swati Mestri
Swati Mestri holds a bachelor's degree in Electronics Engineering and has worked as a content editor since 2019. She has experience editing research documents across technology, health care, and materials science, and has a particular interest in technology and space. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Dozens of genes tied to OCD and tic disorders discovered (2026, September 1) retrieved 1 September 2026 from https://medicalxpress.com/news/2026-08-dozens-genes-ocd-tic-disorders.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.